IR Biosciences Holdings Inc.
IRBS · OTC
12/31/2010 | 12/31/2009 | 12/31/2008 | 12/31/2007 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $3 | $0 |
| + Debt | $4 | $6 | $7 | $0 |
| Enterprise Value | $4 | $6 | $4 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$4 | -$4 | -$5 | -$6 |
| % Margin | – | – | – | – |
| Net Income | -$5 | -$6 | -$6 | -$5 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.31 | -0.49 | -0.49 | -0.5 |
| % Growth | 36.7% | 0% | 2% | – |
| Operating Cash Flow | -$0 | -$3 | -$5 | -$2 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$3 | -$5 | -$2 |